Искусственные генетические системы. Том 1 - Патрушев Л.И.
Скачать (прямая ссылка):
256. De KruifJ., Terstappen L., Boel E., Logtenberg T. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library // Proc. Nat. Acad. Sci. USA. 1995. Vol. 92. P. 3938-3942.
257. Griffiths A.D., Williams S.C., Hartley O. et al. Isolation of high affinity human antibodies directly from large synthetic repertoires // EMBO J.
1994. Vol. 13. P. 3245-3260.
258. KnappikA., Ge L., Hanegger A. et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides // J. Mol. Biol. 2000. Vol. 296. P. 57-86.
259. Desiderio A., Franconi R., Lopez M. et al. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold // Ibid. 2001. Vol. 310, N 3. P. 603-615.
260. Schier R., McCall A., Adams G.P. et al. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity' determining regions in the center of the antibody binding site // Ibid. 1996. Vol. 263. P. 551-567.
261. Yang W.P., Green K., Pinz S.S. et al. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range // Ibid. 1995. Vol. 254. P. 392-403.
262. Low N.M., Holliger P.H., Winter G. Mimicking somatic hypermutation: Affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain // Ibid. 1996. Vol. 260. P. 359-368.
263. Huie M.A., Cheung M.C., Muench M.O. et al. Antibodies to human fetal erythroid cells from nonimmune phage antibody library I I Proc. Nat. Acad. Sci. USA. 2001. Vol. 98, N 5. P. 2682-2687.
264. Vaughan TJ., Williams A.J., Pritchard K. et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library // Nature Biotechnol. 1996. Vol. 14, N 3. P. 309-314.
265. Sblattero D., Bradbury A. Exploiting recombination in single bacteria to make large phage antibody libraries // Ibid. 2000. Vol. 18. P. 75-80.
266. De Haard H.J., Van Neer N., Reurs A. et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic
analysis of high affinity antibodies I I J. Biol. Chem. 1999. Vol. 274, N 26. P. 18218-18230.
267. Sheets M.D., Amersdorfer P., Finnern R. et al. Efficient construction of a large nonimmune phage antibody library; the production of panels of high affinity human single-chain antibodies to protein antigens // Proc. Nat. Acad. Sci. USA. 1998. Vol. 95, N 2. P. 6157-6162.
268. Sblattero D., Lou J., Marzari R., Bradbury A. In vivo recombination as a tool to generate molecular diversity in phage antibody libraries // J. Biotechnol. 2001. Vol. 74, N 4. P. 303-315.
269. De Wildt R.M., Mundy C.R., Gorick B.D., Tomlinson I.M. Antibody arrays for high-throughput screening of antibody-antigen interactions // Nature Biotechnol. 2000. Vol. 18, N 9. P. 989-994.
270. Griffiths A.D., Duncan A.R. Strategies for selection of antibodies by phage display // Curr. Opin. Biotechnol. 1998. Vol. 9. P. 102-108.
271. Bradbury A., Velappan N., Verzillo V. et al. Antibodies in proteomics 1: Generating antibodies // Trends Biotechnol. 2003. Vol. 21. P. 275-281.
272. Bradbury A., Velappan N., Verzillo V. et al. Antibodies in proteomics II; Screening, high-throughput characterization and downstream applications // Ibid. P. 312-317.
273. Tramontano A., Janda K.D., Lerner RA. Catalytic antibodies // Science. 1986. Vol. 234. P. 1566-1570.
274. Pollack SJ., Jacobs J.W., Schultz P.G. Selective chemical catalysis by an antibody // Ibid. P. 1570-1573.
275. Wentworth P. Antibody design by man and nature // Ibid. 2002. Vol. 296. P. 2247-2249.
276. Wentworth P., Janda K.D. Catalytic antibodies // Curr. Opin. Chem. Biol. 1998. Vol. 2, N 1. P. 138-144.
277. Janda K.D., Shevlin C.G., Lerner RA. Antibody catalysis of a disfavored chemical transformation // Science. 1993. Vol. 259, N 5094. P. 490-493.
278. Wentworth P., Jr., Datta A., Smith S. et al. Antibody catalysis of BAc2 aryl carbamate ester hydrolysis: A highly disfavored chemical process // J. Amer. Chem. Soc. 1997. Vol. 119, N 9. P. 2315-2316.
279. Wentworth P., Datta A., Blakey D. et al. Toward antibody-directed “abzyme” prodrug therapy, ADAPT: Carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing // Proc. Nat. Acad. Sci. USA. 1996. Vol. 93, N 2. P. 799-803.
280. Shabat D., Lode H.N., Pertl U. et al. In vivo activity in a catalytic antibody -prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy // Ibid. 2001. Vol. 98. P. 7528-7533.
281. Li Т., Janda K.D., Ashley J.A., Lerner R.A. Antibody catalyzed cationic cyclization // Science. 1994. Vol. 264, N 5163. P. 1289-1293.
282. Toker J.D., Wentworth P., Jr., Hu Y. et al. Antibody-catalysis of a bimol-ecular asymmetric 1,3-dipolar cycloaddition reaction // J. Amer. Chem. Soc. 2000. Vol. 122, N 13. P. 3244-3245.
